EMPLOYMENT AGREEMENTEmployment Agreement • August 7th, 2013 • Amag Pharmaceuticals Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (the “Agreement”) is entered into as of June 20, 2013 (the “Effective Date”) by and between (i) AMAG Pharmaceuticals, Inc., a Delaware corporation with offices at 100 Hayden Avenue, Lexington, MA 02421 (together with its subsidiaries and affiliates, the “Company”), and (ii) Steven Caffe, M.D., an individual residing at [address] (“you”).
AMAG PHARMACEUTICALS, INC. NON-QUALIFIED STOCK OPTION AGREEMENT FOR NON- EMPLOYEE DIRECTORSNon-Qualified Stock Option Agreement • August 7th, 2013 • Amag Pharmaceuticals Inc. • Pharmaceutical preparations
Pursuant to the AMAG Pharmaceuticals, Inc. Third Amended and Restated 2007 Equity Incentive Plan as amended through the date hereof (the “Plan”), AMAG Pharmaceuticals, Inc. (the “Company”) hereby grants to the Optionee named above, who is a Director of the Company but is not an employee of the Company, an option (the “Stock Option”) to purchase on or prior to the Expiration Date specified above all or part of the number of shares of Common Stock, par value $0.01 per share (the “Stock”), of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein and in the Plan. This Stock Option is not intended to be an “incentive stock option” under Section 422 of the Internal Revenue Code of 1986, as amended.
AMAG PHARMACEUTICALS, INC. NON-QUALIFIED STOCK OPTION AGREEMENT FOR COMPANY EMPLOYEESNon-Qualified Stock Option Agreement • August 7th, 2013 • Amag Pharmaceuticals Inc. • Pharmaceutical preparations
Pursuant to the AMAG Pharmaceuticals, Inc. Third Amended and Restated 2007 Equity Incentive Plan as amended through the date hereof (the “Plan”), AMAG Pharmaceuticals, Inc. (the “Company”) hereby grants to the Optionee named above an option (the “Stock Option”) to purchase on or prior to the Expiration Date specified above all or part of the number of shares of Common Stock, par value $0.01 per share (the “Stock”) of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein and in the Plan. This Stock Option is not intended to be an “incentive stock option” under Section 422 of the Internal Revenue Code of 1986, as amended.
LICENSE AGREEMENTLicense Agreement • August 7th, 2013 • Amag Pharmaceuticals Inc. • Pharmaceutical preparations • New York
This License Agreement (the “Agreement”), is made and entered into on June 6, 2013 (the “Effective Date”) by and between (i) AMAG Pharmaceuticals, Inc., a Delaware corporation, with its principal place of business located at 100 Hayden Ave., Lexington, MA 02421 (“AMAG”) and (ii) Access Pharmaceuticals, Inc., a Delaware corporation, with its principal place of business located at 2600 Stemmons Freeway, Suite 176, Dallas TX 75207 (“Access”) (AMAG and Access are each a “Party,” and collectively the “Parties”).
AMAG PHARMACEUTICALS, INC. INCENTIVE STOCK OPTION AGREEMENT FOR COMPANY EMPLOYEESIncentive Stock Option Agreement • August 7th, 2013 • Amag Pharmaceuticals Inc. • Pharmaceutical preparations
Pursuant to the AMAG Pharmaceuticals, Inc. Third Amended and Restated 2007 Equity Incentive Plan as amended through the date hereof (the “Plan”), AMAG Pharmaceuticals, Inc. (the “Company”) hereby grants to the Optionee named above an option (the “Stock Option”) to purchase on or prior to the Expiration Date specified above all or part of the number of shares of Common Stock, par value $0.01 per share (the “Stock”), of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein and in the Plan.
AMAG PHARMACEUTICALS, INC. RESTRICTED STOCK UNIT AWARD AGREEMENT FOR COMPANY EMPLOYEESRestricted Stock Unit Award Agreement • August 7th, 2013 • Amag Pharmaceuticals Inc. • Pharmaceutical preparations
Pursuant to the AMAG Pharmaceuticals, Inc. Third Amended and Restated 2007 Equity Incentive Plan as amended through the date hereof (the “Plan”), AMAG Pharmaceuticals, Inc. (the “Company”) hereby grants an award of the number of Restricted Stock Units listed above (an “Award”) to the Grantee named above. Each Restricted Stock Unit shall relate to one share of Common Stock, par value $0.01 per share (the “Stock”) of the Company.
AMAG PHARMACEUTICALS, INC. RESTRICTED STOCK UNIT AWARD AGREEMENT FOR NON- EMPLOYEE DIRECTORSRestricted Stock Unit Award Agreement • August 7th, 2013 • Amag Pharmaceuticals Inc. • Pharmaceutical preparations
Pursuant to the AMAG Pharmaceuticals, Inc. Third Amended and Restated 2007 Equity Incentive Plan as amended through the date hereof (the “Plan”), AMAG Pharmaceuticals, Inc. (the “Company”) hereby grants an award of the number of Restricted Stock Units listed above (an “Award”) to the Grantee named above. Each Restricted Stock Unit shall relate to one share of Common Stock, par value $0.01 per share (the “Stock”) of the Company.
QUALITY AGREEMENTQuality Agreement • August 7th, 2013 • Amag Pharmaceuticals Inc. • Pharmaceutical preparations
This document constitutes the Quality Agreement (“Agreement”) between Packaging Coordinators, Inc. (“PCI”) and AMAG Pharmaceuticals, Inc. (“AMAG”) for product storage and commercial packaging and labeling services, more specifically with regard to 20mL 1ct and 10ct (WIP, FG) Feraheme (“Services”).
